Have a personal or library account? Click to login
Restoration of Meibomian Gland Functionality with Novel Mesenchymal Stem Cell-Derived Product “Derived-Multiple Allogeneic Proteins Paracrine Signaling (d-MAPPS)”: A Case Report Cover

Restoration of Meibomian Gland Functionality with Novel Mesenchymal Stem Cell-Derived Product “Derived-Multiple Allogeneic Proteins Paracrine Signaling (d-MAPPS)”: A Case Report

EABR. Experimental and Applied Biomedical Research
Volume 24 (2023): Issue 2 (June 2023)
By: Carl Randall Harrell and  Vladislav Volarevic  
Open Access
|Jun 2023

Authors

Carl Randall Harrell

Regenerative Processing Plant, Florida, USA

Vladislav Volarevic

drvolarevic@yahoo.com

University of Kragujevac, Faculty of Medical Sciences, Department for Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
DOI: https://doi.org/10.2478/sjecr-2020-0059 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 169 - 174
Submitted on: Feb 24, 2020
|
Accepted on: Mar 17, 2020
|
Published on: Jun 20, 2023
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Meibomian gland dysfunction,
therapy,
mesenchymal stem cells,
d-MAPPS
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2023 Carl Randall Harrell, Vladislav Volarevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 24 (2023): Issue 2 (June 2023)Next article